The deal is aimed at expanding the clinical trial site network of Eximia. Credit: Michal Jarmoluk from Pixabay.

Eximia Research Network has announced the acquisition of Tidewater Clinical Research, marking a significant expansion of its national clinical trial site network.

Established in 1994, Tidewater Clinical Research focuses on Women’s Health and Ophthalmology clinical trials in the Hampton Roads/Eastern Virginia region in the US.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The integration of Tidewater’s capabilities and patient database with Eximia’s extensive resources is expected to enhance clinical trial experiences.

Tidewater owner Kelley Fleming said: “Tidewater Clinical Research is proud to announce our integration into the Eximia Research Network, marking a significant step forward in enhancing clinical research accessibility and quality of care for diverse patient populations.”

Tidewater co-owner April Rusch said: “Under the Eximia umbrella, Tidewater is poised to broaden its impact on patient health and contribute to the advancement of medical research in ever-expanding medical subspecialty areas.”

See Also:

For the transaction, David Bogart and Devak Patel from Viking Mergers & Acquisitions served as advisers.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Viking Mergers & Acquisitions, which has been in operation since 1996, is a business broker in the Southeast US. It has a track record of having sold over 850 businesses.

Eximia Research Network CEO Dr Ella Grach said: “We are excited to welcome Tidewater Clinical Research to the Eximia network.

“Their expertise in Women’s Health and Ophthalmology complements our mission to drive innovation and improve patient outcomes. This acquisition enhances our ability to serve diverse populations and support groundbreaking clinical research nationwide.”

In October last year, Eximia secured a growth capital investment from private investment company VSS Capital Partners (VSS).

The companies did not disclose the financial terms of the deal.